Carregant...
Different impact of factor VIII products on inhibitor development?
Inhibitors are the most serious side effect of haemophilia treatment; they occur in 25–30 % of all patients with severe haemophilia A. Over the last 2 decades, conflicting data on the impact of clotting products have been published. Due to small studies of selected cases, appreciation of the impact...
Guardat en:
| Publicat a: | Thromb J |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056474/ https://ncbi.nlm.nih.gov/pubmed/27766057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-016-0102-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|